These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29196251)

  • 41. Stroke and Disease Progression During Long-Term Follow-Up of Patients with Moyamoya Disease Older Than 50 Years.
    Sakai R; Hara S; Inaji M; Tanaka Y; Nariai T; Maehara T
    World Neurosurg; 2024 Jul; 187():e898-e907. PubMed ID: 38734172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ipsilateral late stroke after revascularization surgery for patients with Moyamoya disease.
    Araki Y; Yokoyama K; Uda K; Kanamori F; Mamiya T; Nishihori M; Sumitomo M; Okamoto S; Izumi T
    Acta Neurochir (Wien); 2021 May; 163(5):1493-1502. PubMed ID: 33624115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A; Smith ER; Robertson R; Scott RM
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differing Surgical Outcomes in a Multiethnic Cohort Suggest Racial Phenotypes in Moyamoya Disease.
    Feghali J; Xu R; Yang W; Liew J; Tamargo RJ; Marsh EB; Huang J
    World Neurosurg; 2019 Aug; 128():e865-e872. PubMed ID: 31082553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical management of Moyamoya disease and syndrome: Current concepts and personal experience.
    Thines L; Petyt G; Aguettaz P; Bodenant M; Himpens FX; Lenci H; Henon H; Gauthier C; Hossein-Foucher C; Cordonnier C; Lejeune JP
    Rev Neurol (Paris); 2015 Jan; 171(1):31-44. PubMed ID: 25555850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management.
    Rashad S; Fujimura M; Niizuma K; Endo H; Tominaga T
    Neurosurg Rev; 2016 Oct; 39(4):615-23. PubMed ID: 27180559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ischemic Stroke in Young Adults with Moyamoya Disease: Prognostic Factors for Stroke Recurrence and Functional Outcome after Revascularization.
    Zhao M; Deng X; Gao F; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
    World Neurosurg; 2017 Jul; 103():161-167. PubMed ID: 28408257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography.
    King JA; Armstrong D; Vachhrajani S; Dirks PB
    J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term Outcomes After Encephaloduroarteriosynangiosis in Adult Patients with Moyamoya Disease Presenting with Ischemia.
    Bao XY; Zhang Y; Wang QN; Zhang Q; Wang H; Zhang ZS; Li DS; Duan L
    World Neurosurg; 2018 Jul; 115():e482-e489. PubMed ID: 29684518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults.
    Jeon JP; Kim JE; Cho WS; Bang JS; Son YJ; Oh CW
    J Neurosurg; 2018 Mar; 128(3):793-799. PubMed ID: 28474994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Encephaloduroarteriosynangiosis for adult intracranial arterial steno-occlusive disease: long-term single-center experience with 107 operations.
    Gonzalez NR; Dusick JR; Connolly M; Bounni F; Martin NA; Van de Wiele B; Liebeskind DS; Saver JL
    J Neurosurg; 2015 Sep; 123(3):654-61. PubMed ID: 26067617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Asymptomatic Moyamoya Disease in a North American Adult Cohort.
    Lai PMR; Gomez-Paz S; Patel NJ; Frerichs KU; Thomas AJ; Aziz-Sultan MA; Patel AB; Ogilvy CS; Du R
    World Neurosurg; 2022 May; 161():e146-e153. PubMed ID: 35092810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
    Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
    Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
    J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Surgery and Antiplatelet Therapy in Ten-Year Follow-Up from the Registry Study of Research Committee on Moyamoya Disease in Japan.
    Yamada S; Oki K; Itoh Y; Kuroda S; Houkin K; Tominaga T; Miyamoto S; Hashimoto N; Suzuki N;
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):340-9. PubMed ID: 26654669
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meta-Analysis of Prognosis of Different Treatments for Symptomatic Moyamoya Disease.
    Li Q; Gao Y; Xin W; Zhou Z; Rong H; Qin Y; Li K; Zhou Y; Wang J; Xiong J; Dong X; Yang M; Liu Y; Shen J; Wang G; Song A; Zhang J
    World Neurosurg; 2019 Jul; 127():354-361. PubMed ID: 30995556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Revascularization of Moyamoya Angiopathy in Older Adults.
    Williamson RW; Abla AA; Zabramski JM; Nakaji P; Spetzler RF; Wanebo JE
    World Neurosurg; 2017 Mar; 99():37-40. PubMed ID: 27890765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis.
    Wouters A; Smets I; Van den Noortgate W; Steinberg GK; Lemmens R
    Acta Neurol Belg; 2019 Sep; 119(3):305-313. PubMed ID: 31215004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.